Serina Therapeutics to Develop Novel TD Treatment
Serina Therapeutics is advancing SER-270 (POZ-VMAT2i), a once-weekly injectable vesicular monoamine transporter 2 (VMAT2) inhibitor, for tardive dyskinesia (TD)....
Jon Napitupulu
Bio Usawa and Sartorius Partner to Expand Biopharmaceutical Manufacturing in Africa
Bio Usawa and Sartorius Stedim Biotech Forge Partnership to Bolster Africa’s Biopharma Capabilities Bio Usawa, a Rwandan biotechnology company,...
NeuroStar Publication in JAACAP Open Shows Efficacy in Depressed Adolescents
Real-world data from the NeuroStar TrakStar Clinical Database, the largest repository of its kind for depression outcomes, reveals promising...
Sandoz to Acquire Just-Evotec Biologics in Toulouse
Sandoz’s proposed acquisition of Just-Evotec Biologics (JEB) for approximately $300 million marks a significant move to solidify its position...
Cardiff Oncology Announces Positive Phase 2 Trial Data in mCRC
Cardiff Oncology Reports Promising Phase 2 Onvansertib Data in RAS-Mutated Metastatic Colorectal Cancer Cardiff Oncology has unveiled positive interim...
Cardiff Oncology Q2 2025 Results: Business Update
Cardiff Oncology, a clinical-stage biotech focusing on PLK1 inhibition in cancer treatment, recently completed enrollment in its crucial Phase...
AscellaHealth and Abeona Partner to Provide Cell-Based Gene Therapy for Rare Disease
AscellaHealth’s partnership with Abeona Therapeutics in the successful commercialization of Zevaskyn™, a groundbreaking gene therapy for recessive dystrophic epidermolysis...
NewGen Expands US Presence with Cytometry Tech Acquisition
NewGenIVF Group’s acquisition of cytometry technology and assets, including 18 cell-sorting systems and related patents, marks a decisive move...
Calidi’s Stem-Cell Sarcoma Therapy Gets FDA Fast Track
Calidi Biotherapeutics has secured FDA Fast Track designation for CLD-201 (Supernova), its allogeneic adipose stem-cell-loaded oncolytic virus for treating...
Cognition Therapeutics Shows Zervimesine’s Impact on Dementia and Alzheimer’s
Cognition Therapeutics Presents Promising Zervimesine Data at AAIC 2025, Highlighting Potential in Dementia with Lewy Bodies and Alzheimer’s Disease...